Document Detail


Innovative pharmacologic approaches to cardiopulmonary resuscitation.
MedLine Citation:
PMID:  11975769     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The survival rate of patients undergoing cardiopulmonary resuscitation is 5 to 15%. New cardiopulmonary resuscitation treatment approaches under investigation include the use of vasopressin as a vasopressor, amiodarone for the treatment of ventricular tachyarrhythmias, and adenosine antagonists (i.e., theophylline) for bradyasystolic rhythms. More innovative approaches include the use of thyroid hormone and endothelin.
Authors:
T Kelsch; K Kikuchi; S Vahdat; W H Frishman
Related Documents :
19698849 - Influence of prosthesis-patient mismatch on exercise-induced arrhythmias: a further asp...
7068479 - Distribution of cardiac output during static exercise in the conscious cat.
16290969 - Oxygen pulse during exercise is related to resting systolic and diastolic left ventricu...
9665219 - Relative efficacy of medical therapy and revascularization for improving exercise capac...
7095909 - Effect of nitrate on determinants of myocardial oxygen consumption during exercise.
7586419 - Left ventricular dysfunction on exercise long-term after total repair of tetralogy of f...
12894999 - Fate of melanocytes during development of the hair follicle pigmentary unit.
7473239 - Ingestion of branched-chain amino acids and tryptophan during sustained exercise in man...
8531619 - Validation of a cycle ergometry equation for predicting steady-rate vo2 in obese women.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Heart disease (Hagerstown, Md.)     Volume:  3     ISSN:  1521-737X     ISO Abbreviation:  Heart Dis     Publication Date:    2001 Jan-Feb
Date Detail:
Created Date:  2002-04-26     Completed Date:  2002-05-29     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  100887299     Medline TA:  Heart Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  46-54     Citation Subset:  IM    
Affiliation:
Department of Medicine, New York Medical College, Westchester County Medical Center, Valhalla, New York, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
American Heart Association
Animals
Anti-Arrhythmia Agents / standards,  therapeutic use*
Cardiopulmonary Resuscitation* / standards
Cardiovascular Diseases / therapy
Clinical Trials as Topic
Combined Modality Therapy / standards
Endothelin-1 / therapeutic use
Humans
Practice Guidelines as Topic
Treatment Outcome
United States / epidemiology
United States Food and Drug Administration
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 0/Endothelin-1
Comments/Corrections
Comment In:
Heart Dis. 2001 Jan-Feb;3(1):1   [PMID:  11975763 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antioxidant vitamins and enzymatic and synthetic oxygen-derived free radical scavengers in the preve...
Next Document:  Verapamil revisited: a transition in novel drug delivery systems and outcomes.